DOI RECORD
Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II–III Lung Adenocarcinoma: A Multicenter CReGYT-03 ALK Study
Akira Hamada, Shinkichi Takamori, Asato Hashinokuchi, Mototsugu Shimokawa, Kenichi Suda, Shinya Katsumata, Naoki Haratake, Kotaro Nomura, Yoshihisa Shimada, Takahide Toyoda, Takuya Watanabe, Kazuki Hayasaka, Masaoki Ito, Shuta Ohara, Shota Fukuda, Tomoyo Fukami, Hana Oiki, Kentaro Minegishi, Kantaro Hara, Mao Yoshikawa, Ken Suzawa, Kazuhiko Shien, Kosuke Fujino, Takamasa Koga, Keisuke Kosai, Atsushi Kamigaichi, Hirotsugu Notsuda, Taichi Matsubara, Shinya Tane, Miyuki Abe, Somei Matsuo, Sho Wakasu, Satoshi Muto, Satoru Okada, Tomoki Nishimura, Michihito Toda, Makoto Endo, Kazuki Takada, Keigo Sekihara, Jun Suzuki, Hikaru Watanabe, Ryo Fujikawa, Hironobu Hoshino, Kazuhiko Kuwahara, Norihiko Ikeda, Satoshi Shiono, Junichi Soh, Yasuhisa Ohde, Yasuhiro Tsutani iD
DOI10.1245/s10434-026-20626-z
PublisherSpringer Science and Business Media LLC
Journal / SourceAnnals of Surgical Oncology
Published2026-10-05
Metadata Deposited2026-10-05 (updated: 2026-10-06)
Subject—
Languageen
ISSN1068-9265, 1534-4681
Typejournal-article
Volume / Issue / Pages— / — / —
Citations0
References deposited23
Access / license metadataAccess not determined License 1 ↗A reuse license does not by itself establish whether the full text is freely readable.
